The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

German Hospital Treats US Ebola Patient Infected in Congo

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Alcohol Emergencies: When Is It More Than Intoxication?

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

Risk Stratification May ID Paraneoplastic Dermatomyositis

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

Elevated Interferon Alfa May Reveal Sjögren Disease Subtype

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

News All Time

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

Pernicious Anemia: How a Fatal Disease Became Treatable

Once nearly always fatal, pernicious anemia became treatable through a series of discoveries linking the stomach, liver, and ultimately vitamin B12.

Uveitis Patterns Vary in Relation to Spondyloarthritis Type

Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms.

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

The Essential Clinical Research You’re Probably Not Reading

Qualitative research has long been viewed as less rigorous and less important — but that’s changing. Here’s where to find the highest-quality studies and how to use them to help your patients.

Can CRISPR Make CAR T Safer and More Scalable?

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Pain Persists Despite Low Inflammation in Many With Early RA

Patients newly diagnosed with rheumatoid arthritis often experience unacceptable pain at 2 years despite having low levels of inflammation, a study finds.

AI Is Making Uneven Inroads in Pulmonary Medicine

AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and prediction, but significant gaps between development and deployment.

Abrocitinib Boosts Skin Clearance and Itch Relief in AD

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows.

Limited Data for JAK Inhibitors in SSc Described in Study

In patients with systemic sclerosis, JAK inhibitors show comparable effectiveness to standard immunosuppressants, but many stop therapy due to treatment failure or adverse events.

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

When Patients Arrive With AI Diagnoses

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

Hydrolyzed Rice Formula Effective in Cow’s Milk Allergy

Hydrolyzed rice formula serves as an additional nutritional option for managing cow’s milk protein allergy in infants.

Which Medications Increase Heat-Related Risk in Patients?

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.

Maternal RSV Shot Largely Safe, Except for Hypertension Risk

Vaccination against respiratory syncytial virus given late in pregnancy is not linked to adverse birth outcomes but is linked to a slightly increased risk for hypertensive disorders of pregnancy.

US FDA Approves Vera's Kidney Disease Drug

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...